Polypropylene glycol is a selective binding inhibitor for LTA and other structurally related TLR2 agonists-Reference-Cited by-同舟云学术

Polypropylene glycol is a selective binding inhibitor for LTA and other structurally related TLR2 agonists

Published:2008-03 Issue:3 Volume:38 Page:797-808
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Draing Christian,Traub Stephanie,Deininger Susanne,Mang Philippa,Möller Heiko M.,Manso Miguel,Rossi Francois,Morath Siegfried,Hartung Thomas,von Aulock Sonja

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference49 articles.

1. Recognition of microbial infection by Toll-like receptors

2. GENETIC ANALYSIS OF HOST RESISTANCE: Toll-Like Receptor Signaling and Immunity at Large

3. Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

4. Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 2

5. Lipopolysaccharide Rapidly Traffics to and from the Golgi Apparatus with the Toll-like Receptor 4-MD-2-CD14 Complex in a Process That Is Distinct from the Initiation of Signal Transduction

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction of IL-10-balanced immune profiles following exposure to LTA from Staphylococcus epidermidis;Experimental Dermatology;2018-04

2. Scavenger receptor for lipoteichoic acid is involved in the potent ability of Lactobacillus plantarum strain L-137 to stimulate production of interleukin-12p40;International Immunopharmacology;2015-04

3. Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test;ALTEX;2013

4. Apolipoprotein B100 is a suppressor of Staphylococcus aureus-induced innate immune responses in humans and mice;European Journal of Immunology;2012-08-28

5. Systematic Review of Membrane Components of Gram-Positive Bacteria Responsible as Pyrogens for Inducing Human Monocyte/Macrophage Cytokine Release;Frontiers in Pharmacology;2012